as on January 28, 2026 at 9:40 pm IST
Day's Low
Day's High
0.42%
Downside
4.62%
Upside
52 Week's Low
52 Week's High
48.42%
Downside
9.12%
Upside
Check Acadia Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.5B
EPS (TTM)
0.8184
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.13%
PE Ratio (TTM)
17.33
Industry PE ratio
5.553333333333334
PEG Ratio
-0.42
EBITDA
108.5M
Revenue (TTM)
1.0B
Profit Margin
24.94%
Return On Equity TTM
34.95%
Track how Acadia Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Acadia Pharmaceuticals Inc. in the last 5 years
Lowest (-62.85x)
December 31, 2023
Industry (5.55x)
January 28, 2026
Today (17.33x)
January 28, 2026
Highest (89.66x)
June 30, 2024
Today’s Price to Earnings Ratio: 17.33x
Compare market cap, revenue, PE, and other key metrics of Acadia Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.5B | -47.11% | 17.33 | 24.94% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Acadia Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Acadia Pharmaceuticals Inc. investment value today
Current value as on today
₹1,47,170
Returns
₹47,170
(+47.17%)
Returns from Acadia Pharmaceuticals Inc. Stock
₹41,196 (+41.2%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 26 analysts
73.08%
Buy
23.08%
Hold
3.85%
Sell
Based on 26 analysts, 73.08% of analysts recommend a 'BUY' rating for Acadia Pharmaceuticals Inc.. Average target price of $30.84
Get share price movements and forecasts by analysts on Acadia Pharmaceuticals Inc..
What analysts predicted
15.76%UPSIDE
Target Price
$30.84
Current Price
$25.98
Analyzed by
26 Analysts
Target
$30.84
Acadia Pharmaceuticals Inc. target price $30.84, a slight upside of 15.76% compared to current price of $25.98. According to 26 analysts rating.
Search interest for Acadia Pharmaceuticals Inc. Stock has increased by 49% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:49% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 year, ACAD stock has moved up by 42.4%
Best in 3 Years
![]()
In the last 3 years, ACAD has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 244.31M → 278.63M (in $), with an average increase of 6.4% per quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 18.98M → 71.77M (in $), with an average increase of 45.8% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 5.9%
| Organisation | Acadia Pharmaceuticals Inc. |
| Headquarters | 12830 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Ms. Catherine E. Owen Adams |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Thomas Andrew Garner | Executive VP & Chief Commercial Officer |
Mr. Rob Ackles | Senior VP & Chief People Officer |
Ms. Catherine E. Owen Adams | CEO & Director |
Ms. Jennifer J. Rhodes J.D. | Executive VP, Chief Legal Officer & Secretary |
Dr. Elizabeth H. Z. Thompson Ph.D. | Executive VP and Head of Research & Development |
Mr. James K. Kihara | Senior Vice President of Finance |
Ms. Allyson McMillan Youngblood | Senior Vice President of Rare Disease Franchise |
Mr. Mark C. Schneyer | Executive VP & CFO |
Mr. Scott Cenci | Senior VP, Chief Information & Data Officer |
Mr. Albert S. Kildani | Senior Vice President of Investor Relations & Corporate Communications |
Acadia Pharmaceuticals Inc. share price today is $25.98 as on . Acadia Pharmaceuticals Inc. share today touched a day high of $27.18 and a low of $25.87.
Acadia Pharmaceuticals Inc. share touched a 52 week high of $28.35 on and a 52 week low of $13.4 on . Acadia Pharmaceuticals Inc. stock price today i.e. is trending at $25.98,which is 8.36% down from its 52 week high and 93.88% up from its 52 week low.
Acadia Pharmaceuticals Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Acadia Pharmaceuticals Inc. (ACAD) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Acadia Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Acadia Pharmaceuticals Inc. share’s latest price of $25.98 as on January 28, 2026 at 9:40 pm IST, you will get 0.3849 shares of Acadia Pharmaceuticals Inc.. Learn more about
fractional shares .
Acadia Pharmaceuticals Inc. stock has given -47.11% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?